| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |